bluebird bio Inc. (BLUE) Return on Sales by Net Profit

Corporate emblem and logo of Bluebird Bio (BLUE)

bluebird bio, Inc. (BLUE) is a pioneer in treating rare blood pathologies using unique lentiviral technologies. The business is based on creating gene therapies from modified patient cells. The integral net margin indicator demonstrates current profitability, where the value -192.40 reflects the metric's balance. However, high product implementation costs and operational complexities create risks in the competitive struggle for market share.

bluebird bio, Inc. (BLUE) - Company Sales Margin from 07/04/2022 to 06/07/2025

Analytical breakdowns and data insights for company bluebird bio, Inc. (BLUE)

- market value and analyst target forecast:
Analysis of all company metrics:bluebird bio - BLUE
Flagship merchandise of bluebird bio, Inc

bluebird bio, Inc. (BLUE) focuses on developing innovative one-time gene therapies to treat severe hereditary blood disorders. Mathematically, this process is reflected through the ratio of net income to total revenue. This metric measures the efficiency of converting revenue into final capital after deducting all operating and tax expenses. By analyzing the net profit margin of trading and production activities, an investor assesses the business's resilience to inflation. The trend in the net profit margin of trading and production activities reveals the balance between costly research and development and the market value of patient cures.

Direct competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Benitec Biopharma - Return on Sales by Net Profit|DSGN: Net Return on Sales|RCKT: Return on Sales by Net Profit|FDMT - Net Sales Margin|LXEO: Net Sales Margin|Korro Bio Inc. - Net Profit Rate|EDIT (editasmedicine.com) - Net Sales Margin|Net Margin SLN|Net Margin ProQR Therapeutics NV (PRQR)|Codexis - Net Return on Sales|Net Margin Sangamo SGMO|NAUT: Net Return on Sales|MGX: Return on Sales by Net Profit|Net Margin Precision BioSciences|GBIO (generationbio.com) - Return on Sales by Net Profit|Net Margin boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Net Sales Margin|Net Return on Sales IMNN (Imunon, Inc.)|Net Sales Margin PHIO|MBIO - Net Margin|Net Sales Margin RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Net Margin|Applied DNA - Net Sales Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX